Vivanta 24mg+26mg Tablet contains Sacubitril 24 mg + Valsartan 26 mg. It is an angiotensin receptor-neprilysin inhibitor (ARNI) used to reduce the risk of cardiovascular death and hospitalization in patients with chronic heart failure with reduced ejection fraction (HFrEF).
Uses:
-
Treatment of chronic heart failure with reduced ejection fraction (HFrEF).
-
Reduces the risk of cardiovascular death.
-
Reduces hospitalization due to heart failure.
-
Improves symptoms and heart function in patients with chronic heart failure.
Dose:
-
Adults: Usually 1 tablet (24 mg/26 mg) twice daily as the starting dose, or as directed by a physician. The dose may be increased gradually based on the patient's response and tolerability.
-
Take the medicine exactly as prescribed by a healthcare professional.
-
Dose and duration depend on the patient's condition and response to treatment.
-
Follow the prescribed dosing schedule.